A New AI in Allergy and Immunology
Paneez Khoury, MD, MHSc, FAAAAI, discusses a fascinating new work group report that details how augmented intelligence (AI) can enhance the specialty of allergy and immunology.
16 Kesä 202240min
2022 Practice Management Workshop
Vivian Hernandez-Trujillo, MD, FAAAAI, discusses the Practice Management Workshop taking place July 22-24, 2022 in Washington, DC. Listen now to learn more about the practical and informative educational sessions and networking opportunities that will take place at this event. (June 8, 2022)
8 Kesä 202220min
Food Allergy Conversations We Didn't Have 5 Years Ago
Food allergy expert Doug Mack, MD, discusses the evolving evidence surrounding food allergy management. This is a great episode for both medical professionals and the general public to learn more about risk from various scenarios, avoidance measures, and ways to help people with food allergy safely and confidently navigate the world.
11 Touko 202259min
Serving the Underserved: A Real World Asthma Study With Promising Applications
Asthma expert Elliot Israel, MD, FAAAAI, discusses the PREPARE trial, the results of which were recently published in The New England Journal of Medicine and presented at the 2022 AAAAI Annual Meeting. This conversation weaves in important dialogue surrounding asthma disparities, as well as details of this landmark study.
4 Touko 202255min
The Mysteries of Mastocytosis
Melody Carter, MD, FAAAAI, discusses the diagnosis, prognosis and management of pediatric and adult mastocytosis. This is an informative discussion for medical professionals and the general public.
21 Huhti 202251min
Exciting Advances in the Treatment of Atopic Dermatitis
Dermatology expert Jonathan Silverberg, MD, PhD, MPH, discusses new treatment options and offers insight to help guide decision making for both patients and clinicians. This is a must listen for staying up to date with all of the recent advances.
5 Huhti 202254min
The Joint Task Force on Practice Parameters
This episode discusses the allergy practice parameters and how clinicians can utilize these resources. Joint Task Force Co-Chairs David Golden, MD, FAAAAI, and Marcus Shaker, MD, MS, FAAAAI, offer their perspective and insight regarding evidence-based medicine and translation into clinical practice.
24 Maalis 20221h 3min
Tezepelumab: A New Frontier for Asthma Treatment
Roxana Siles, MD, FAAAAI, discusses this newly approved biologic that targets thymic stromal lymphopoietin for the treatment of severe asthma. This discussion walks through all the details regarding how best to utilize biologic therapy in asthma management.
23 Helmi 202227min
